Bangor Daily News

FDA approves landmark pancreatic cancer drug that's shown to improve survival

WASHINGTON (AP) — The Food and Drug Administration on Wednesday approved a groundbreaking new drug for the most common form of pancreatic cancer, offering U.S. patients a more effective treatment…

Read the original at Bangor Daily News

More audio from Bangor Daily News